Table 1. Demographic and clinical characteristics of COVID-19 patients.
| Variables | Value (N = 384) |
| Demographics | |
| Age (years) | 59 (23) |
| Sex (male%) | 179 (46.6%) |
| Comorbidities | |
| Hypertension | 123 (32.0%) |
| Diabetes | 54 (14.1%) |
| Coronary heart disease | 27 (7.0%) |
| Symptoms | |
| Fever | 299 (77.9%) |
| Cough | 240 (62.5%) |
| Expectoration | 94 (24.5%) |
| Pharyngalgia | 18 (4.7%) |
| Fatigue | 128 (33.3%) |
| Dyspena | 54 (14.1%) |
| Disease severity | |
| Mild / Severe / Critical group | 157 / 129/ 15 |
| Antiviral treatment | |
| With abidor | 258 (67.2%) |
| With Lianhua Qingwen | 199 (51.8%) |
| With oseltamivir capsules | 68 (17.7%) |
| With hydroxychloroquine, or chloroquine | 95 (24.7%) |
| With ribavirin | 135 (35.2%) |
| With glucocorticoid | 113 (29.4%) |
| Laboratory detections | |
| Leukocyte count (10 9 /L) | 5.2 (4.3) |
| Lymphocyte (10 9 /L) | 0.9 (0.3) |
| Platelet count (10 9 /L) | 268 ± 133 |
| Serum bilirubin (μmol/l) | 27 ± 20 |
| Creatinine (μmol / L) | 55 (28) |
| Outcome | |
| Duration of detectable viral RNA in sputum (days) | 32 ± 21 |
Data are expressed as the mean ± standard deviation, median (interquartile range) or number (percent). Comparisons between groups were performed using one-way ANOVA, the Mann–Whitney U test, or a chi-squared test.